What's new

Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised

Apr 30, 2025 - 13:03
 0
Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

STAT+: NIH plans to reduce animal testing in federally funded research

Next Article

The Pitti Bimbo Networking tour and the first brands!

Related Posts

Human medicines European public assessment report (EPAR): Twynsta, telmisartan,amlodipine, Date of authorisation: 07/10/2010, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0

Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Apr 29, 2025  0

Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0